Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
University of Maryland, Baltimore
University of Maryland, Baltimore
GlaxoSmithKline
Fred Hutchinson Cancer Center
Stanford University
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)